This information was published on 2022-06-16T03:02:47 for IP Right Filed Published.
| Field | Value |
| (210) | 2277080 (IR 1666046) |
| (220) |
09 May 2022
|
| (300) |
GB, 01 Mar 2022, UK00003760364
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | REBTORFA |
| (550) | Word |
| (730) |
Glaxo Group Limited
|
Find out more about publications on the About page.